Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MEETINGS - Meeting on A Future for Nebuliser Therapy (UK) September 1999:

This article was originally published in Clinica

Executive Summary

Management Forum will hold a meeting on A Future for Nebuliser Therapy in London on September 20-21. The performance of current nebulisers will be assessed and delegates will have the opportunity to learn of new multidose inhalers based on the technology of liquids nebulisation. Other discussion topics include the market, the role of nebulisers in gene therapy, and alternatives to nebuliser therapy for acute childhood asthma. Contact Management Forum in the UK for further details. Tel: +44 1483 570 099. Fax: +44 1483 536 424.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT079043

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel